synthesis and analgesic activity evaluation of some agmatine derivatives合成和镇痛活性评价的胍基丁胺衍生品.pdf
文本预览下载声明
Molecules 2006, 11, 393-402
molecules
ISSN 1420-3049
Full Paper
Synthesis and Analgesic Activity Evaluation of Some Agmatine
Derivatives
Hongxia He 1, Mengjia Liu 1, Zhibing Zheng 2,*, Ying Liu 2, Junhai Xiao 2, Ruibin Su 2, Chun
1 2 2
Hu , Jin Li and Song Li
1 School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, 110016,
P.R. China
2 Department of Medicinal Chemistry, Beijing Institute of Pharmacology and Toxicology, Beijing,
100850, P.R. China
E-mail addresses: Zhibing ZHENG: zbzheng@, Mengjia Liu: mj32800@,
Ying Liu: luxin314@, Junhai Xiao: xiaojunhai@, Ruibin Su:
Ruibinsu@Y, Chun HU: Chem2000@163.com, Jin Li: lijin@, Song LI:
lis@
*Author to whom correspondence should be addressed; e-mail: hhx110015@
Received: 10 May 2006 / Accepted: 9 June 2006 / Published: 12 June 2006
Abstract: A series of N,N’-disubstituted-2-nitroethene-1,1-diamine and N,N’-disubstituted-
N’’-cyanoguanidine derivatives were prepared and evaluated for in vivo analgesic activity.
The blood brain barrier (BBB) VolSurf model was used to predict the BBB permeation
profiles of our synthesized compounds. Some compounds show both remarkable analgesic
activity and good BBB permeation profiles, and these compounds might be developed for
treatment of opioid tolerance and dependence.
Keywords: Agmatine derivatives; synthesis; analgesic activity; blood-brain barrier; opioid
dependence.
Introduction
Agmatine (1, Figure 1) is an endogenous ligand of imidazoline receptors [1], and is biologically
active in the nervous system and many other tissues in mammals [2]
显示全部